Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial

Bibliographic Details
Title: Fixed‐dose combination therapy‐based protocol compared with free pill combination protocol: Results of a cluster randomized trial
Authors: Olutobi A. Sanuade, Boni M. Ale, Abigail S. Baldridge, Ikechukwu A. Orji, Gabriel L. Shedul, Tunde M. Ojo, Grace Shedul, Eugenia N. Ugwuneji, Nonye Egenti, Kasarachi Omitiran, Rosemary Okoli, Helen Eze, Ada Nwankwo, Lisa R. Hirschhorn, Aashima Chopra, Jiancheng Ye, Priya Tripathi, Bolanle Banigbe, Namratha R. Kandula, Mark D. Huffman, Dike B. Ojji, the Hypertension Treatment in Nigeria Program Investigators
Source: The Journal of Clinical Hypertension, Vol 25, Iss 2, Pp 127-136 (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
Subject Terms: cluster‐randomized trial, fixed‐dose combination, free pill combination, hypertension, Nigeria, Diseases of the circulatory (Cardiovascular) system, RC666-701
More Details: Abstract Fixed‐dose combination (FDC) therapy is recommended for hypertension management in Nigeria based on randomized trials at the individual level. This cluster‐randomized trial evaluates effectiveness and safety of a treatment protocol that used two‐drug FDC therapy as the second and third steps for hypertension control compared with a protocol that used free pill combinations. From January 2021 to June 2021, 60 primary healthcare centers in the Federal Capital Territory of Nigeria were randomized to a protocol using FDC therapy as second and third steps compared with a protocol that used the same medications in free pill combination therapy for these steps. Eligible patients were adults (≥18 years) with hypertension. The primary outcome was the odds of a patient being controlled at their last visit between baseline to 6‐month follow‐up in the FDC group compared to the free pill group. 4427 patients (mean [SD] age: 49.0 [12.4] years, 70.5% female) were registered with mean (SD) baseline systolic/diastolic blood pressure 155 (20.6)/96 (13.1) mm Hg. Baseline characteristics of groups were similar. After 6‐months, hypertension control rate improved in the two treatment protocols, but there were no differences between the groups after adjustment (FDC = 53.9% versus free pill combination = 47.9%, cluster‐adjusted p = .29). Adverse events were similarly low (
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1751-7176
1524-6175
Relation: https://doaj.org/toc/1524-6175; https://doaj.org/toc/1751-7176
DOI: 10.1111/jch.14632
Access URL: https://doaj.org/article/4b2d93f5be6d4865b749f2dccdbc94f5
Accession Number: edsdoj.4b2d93f5be6d4865b749f2dccdbc94f5
Database: Directory of Open Access Journals
More Details
ISSN:17517176
15246175
DOI:10.1111/jch.14632
Published in:The Journal of Clinical Hypertension
Language:English